You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
1.HYPERTENSION: Capoten (captopril) is indicated for the treatment of hypertension. In using Capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see PRECAUTIONS). Capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of captopril and thiazides are approximately additive. 2. MYOCARDIAL INFARCTION: Capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. The efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. HEART FAILURE: Capoten (captopril) is indicated for the treatment of heart failure. In symptomatic patients it is recommended that Capoten be administered together with a diuretic. 4. DIABETIC NEPHROPATHY: Capoten is indicated for the treatment of diabetic nephropathy in patients with Type 1 insulin- dependent diabetes mellitus.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
1.HYPERTENSION: Capoten (captopril) is indicated for the treatment of hypertension. In using Capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see PRECAUTIONS). Capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of captopril and thiazides are approximately additive. 2. MYOCARDIAL INFARCTION: Capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. The efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. HEART FAILURE: Capoten (captopril) is indicated for the treatment of heart failure. In symptomatic patients it is recommended that Capoten be administered together with a diuretic. 4. DIABETIC NEPHROPATHY: Capoten is indicated for the treatment of diabetic nephropathy in patients with Type 1 insulin- dependent diabetes mellitus.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
1.HYPERTENSION: Capoten (captopril) is indicated for the treatment of hypertension. In using Capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see PRECAUTIONS). Capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of captopril and thiazides are approximately additive. 2. MYOCARDIAL INFARCTION: Capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. The efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. HEART FAILURE: Capoten (captopril) is indicated for the treatment of heart failure. In symptomatic patients it is recommended that Capoten be administered together with a diuretic. 4. DIABETIC NEPHROPATHY: Capoten is indicated for the treatment of diabetic nephropathy in patients with Type 1 insulin- dependent diabetes mellitus.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
1.HYPERTENSION: Capoten (captopril) is indicated for the treatment of hypertension. In using Capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see PRECAUTIONS). Capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of captopril and thiazides are approximately additive. 2. MYOCARDIAL INFARCTION: Capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. The efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. HEART FAILURE: Capoten (captopril) is indicated for the treatment of heart failure. In symptomatic patients it is recommended that Capoten be administered together with a diuretic. 4. DIABETIC NEPHROPATHY: Capoten is indicated for the treatment of diabetic nephropathy in patients with Type 1 insulin- dependent diabetes mellitus.
A flat faced, bevelled edge, capsule-shaped slightly mottled white tablet with a bisect bar on one side and "SQUIBB 450" engraved on the other. Dimensions: 10.2mm x 5.1mm
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
1.HYPERTENSION: Capoten (captopril) is indicated for the treatment of hypertension. In using Capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see PRECAUTIONS). Capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of captopril and thiazides are approximately additive. 2. MYOCARDIAL INFARCTION: Capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. The efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. HEART FAILURE: Capoten (captopril) is indicated for the treatment of heart failure. In symptomatic patients it is recommended that Capoten be administered together with a diuretic. 4. DIABETIC NEPHROPATHY: Capoten is indicated for the treatment of diabetic nephropathy in patients with Type 1 insulin- dependent diabetes mellitus.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
1.HYPERTENSION: Capoten (captopril) is indicated for the treatment of hypertension. In using Capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see PRECAUTIONS). Capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of captopril and thiazides are approximately additive. 2. MYOCARDIAL INFARCTION: Capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. The efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. HEART FAILURE: Capoten (captopril) is indicated for the treatment of heart failure. In symptomatic patients it is recommended that Capoten be administered together with a diuretic. 4. DIABETIC NEPHROPATHY: Capoten is indicated for the treatment of diabetic nephropathy in patients with Type 1 insulin- dependent diabetes mellitus.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
1.HYPERTENSION: Capoten (captopril) is indicated for the treatment of hypertension. In using Capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see PRECAUTIONS). Capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of captopril and thiazides are approximately additive. 2. MYOCARDIAL INFARCTION: Capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. The efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. HEART FAILURE: Capoten (captopril) is indicated for the treatment of heart failure. In symptomatic patients it is recommended that Capoten be administered together with a diuretic. 4. DIABETIC NEPHROPATHY: Capoten is indicated for the treatment of diabetic nephropathy in patients with Type 1 insulin- dependent diabetes mellitus.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
1.HYPERTENSION: Capoten (captopril) is indicated for the treatment of hypertension. In using Capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see PRECAUTIONS). Capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of captopril and thiazides are approximately additive. 2. MYOCARDIAL INFARCTION: Capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. The efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. HEART FAILURE: Capoten (captopril) is indicated for the treatment of heart failure. In symptomatic patients it is recommended that Capoten be administered together with a diuretic. 4. DIABETIC NEPHROPATHY: Capoten is indicated for the treatment of diabetic nephropathy in patients with Type 1 insulin- dependent diabetes mellitus.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
1.HYPERTENSION: Capoten (captopril) is indicated for the treatment of hypertension. In using Capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see PRECAUTIONS). Capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of captopril and thiazides are approximately additive. 2. MYOCARDIAL INFARCTION: Capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. The efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. HEART FAILURE: Capoten (captopril) is indicated for the treatment of heart failure. In symptomatic patients it is recommended that Capoten be administered together with a diuretic. 4. DIABETIC NEPHROPATHY: Capoten is indicated for the treatment of diabetic nephropathy in patients with Type 1 insulin- dependent diabetes mellitus.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
1.HYPERTENSION: Capoten (captopril) is indicated for the treatment of hypertension. In using Capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see PRECAUTIONS). Capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of captopril and thiazides are approximately additive. 2. MYOCARDIAL INFARCTION: Capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. The efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. HEART FAILURE: Capoten (captopril) is indicated for the treatment of heart failure. In symptomatic patients it is recommended that Capoten be administered together with a diuretic. 4. DIABETIC NEPHROPATHY: Capoten is indicated for the treatment of diabetic nephropathy in patients with Type 1 insulin- dependent diabetes mellitus.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
